Study of the binding of chemotherapeutic drugs to patient blood proteins during chemotherapy treatment using infrared spectroscopy
Ukrainian Journal of Medical Science · 09.06.2026 · 32 (2) · 125-140
DOI: 10.37621/ujms.32.2.2026.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ukrainian Journal of Medical Science, online erschienen am 09.06.2026. Verfasst von N.Yu. Pershko und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The method of recording infrared spectra of blood smears with an assessment of the conformational state of albumin and its interaction with chemotherapy drugs is close to the in vivo analysis of drug binding to blood proteins of patients. Changes in the spectral indices of alpha and beta structures after the administration of a chemotherapy drug indicate the ability of albumin to transport the drug, while the absence of changes may indicate a violation of the drug action and a decrease in the effectiveness of chemotherapy. Purpose – study of changes in the conformational state of blood albumin in patients during chemotherapy treatment by analyzing infrared spectra of blood smears, as well as determining the ability of albumin to interact with chemotherapy drugs and the impact of these processes on the effectiveness of therapy. Materials and Methods. The object of the study was blood smears from cancer patients receiving chemotherapy (docetaxel, gemcitabine, carboplatin, paclitaxel, cisplatin). Infrared spectra were studied using our own developed method on a Specord M80 (ATR) spectrophotometer. Statistical processing was performed in LibreOffice 6.4.7.2 and QtiPlot, and spectral indices were calculated using the author's programs "Spectra infra" and "Spectra trio".
Results
Our studies have shown that infrared spectra of blood smears record changes in the Amide I band region, which allows us to assess the state of the transport link in cancer patients. Spectral changes after the administration of a chemotherapy drug in the alpha and beta structures indicate the ability of albumin to bind the drug and transport it. In individual patients, the absence of changes in the α-helix, β-structure, and disordered coil zones indicates the absence of the drug+albumin complex and a violation of the drug delivery mechanism.
Conclusions
The proposed method, based on the analysis of spectral parameters of blood, made it possible to determine the process of drug binding to albumin during its administration. The detected changes in the spectra after infusion correlate with the effectiveness of treatment, while their absence indicates a violation of the binding of the chemotherapeutic agent to blood proteins.
Zitieren
APA
Pershko, N., Levchenko, O., Ponomaryova, O., Kokhanov, I., Sydorenko, M., & Siharova, N. (2026). Study of the binding of chemotherapeutic drugs to patient blood proteins during chemotherapy treatment using infrared spectroscopy. Ukrainian Journal of Medical Science, 32(2), 125-140. https://doi.org/10.37621/ujms.32.2.2026.09
Vancouver
Pershko N, Levchenko O, Ponomaryova O, Kokhanov I, Sydorenko M, Siharova N. Study of the binding of chemotherapeutic drugs to patient blood proteins during chemotherapy treatment using infrared spectroscopy. Ukrainian Journal of Medical Science. 2026;32(2):125-140. doi:10.37621/ujms.32.2.2026.09
BibTeX
@article{Pershko2026,
author = {Pershko, N.Yu. and Levchenko, O.Ye. and Ponomaryova, O.V. and Kokhanov, I.V. and Sydorenko, M.V. and Siharova, N.V.},
title = {Study of the binding of chemotherapeutic drugs to patient blood proteins during chemotherapy treatment using infrared spectroscopy},
journal = {Ukrainian Journal of Medical Science},
year = {2026},
volume = {32},
number = {2},
pages = {125--140},
doi = {10.37621/ujms.32.2.2026.09}
}
EUVIMED